BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barker CIS, Standing JF, Kelly LE, Hanly Faught L, Needham AC, Rieder MJ, de Wildt SN, Offringa M. Pharmacokinetic studies in children: recommendations for practice and research. Arch Dis Child 2018;103:695-702. [PMID: 29674514 DOI: 10.1136/archdischild-2017-314506] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Adiwidjaja J, Boddy AV, McLachlan AJ. Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics. Front Pharmacol 2019;10:1672. [PMID: 32082165 DOI: 10.3389/fphar.2019.01672] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
2 Dubinsky S, Watt K, Saleeb S, Ahmed B, Carter C, Yeung CHT, Edginton A. Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature. Clin Pharmacokinet 2021. [PMID: 34846703 DOI: 10.1007/s40262-021-01085-z] [Reference Citation Analysis]
3 De Zen L, Marchetti F, Barbi E, Benini F. Off-label drugs use in pediatric palliative care. Ital J Pediatr 2018;44:144. [PMID: 30486873 DOI: 10.1186/s13052-018-0584-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
4 Abdel Jalil MH, Abdullah N, Alsous MM, Saleh M, Abu-Hammour K. A systematic review of population pharmacokinetic analyses of digoxin in the paediatric population. Br J Clin Pharmacol 2020;86:1267-80. [PMID: 32153059 DOI: 10.1111/bcp.14272] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Rashid M, Sarfraz M, Arafat M, Hussain A, Abbas N, Sadiq MW, Rasool MF, Bukhari NI. Prediction of lisinopril pediatric dose from the reference adult dose by employing a physiologically based pharmacokinetic model. BMC Pharmacol Toxicol 2020;21:56. [PMID: 32727574 DOI: 10.1186/s40360-020-00429-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Roy H, Bertoldi C, Farrell C, Rousseau E. Prescribing drugs to overweight and obese children: Balancing efficacy and safety. Paediatr Child Health 2021;26:e236-9. [PMID: 34552680 DOI: 10.1093/pch/pxaa108] [Reference Citation Analysis]
7 Ramanan AV, Modi N, de Wildt SN; c4c Learning from COVID-19 Group. Improving clinical paediatric research and learning from COVID-19: recommendations by the Conect4Children expert advice group. Pediatr Res 2021. [PMID: 34099854 DOI: 10.1038/s41390-021-01587-3] [Reference Citation Analysis]
8 Shoji K, Saito J, Nakagawa H, Funaki T, Fukuda A, Sakamoto S, Kasahara M, Momper JD, Capparelli EV, Miyairi I. Population Pharmacokinetics and Dosing Optimization of Vancomycin in Pediatric Liver Transplant Recipients. Microbiol Spectr 2021;9:e0046021. [PMID: 34612690 DOI: 10.1128/Spectrum.00460-21] [Reference Citation Analysis]
9 Agrawal M, Rattan A. How to Treat Sepsis in the Background of Resistance?: Role of Pharmacodynamics / Pharmacokinetics in Treating Sepsis. Indian J Pediatr 2020;87:111-6. [PMID: 31933137 DOI: 10.1007/s12098-019-03153-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Mnkugwe RH, Ngaimisi Kitabi E, Kinung'hi S, Kamuhabwa AAR, Minzi OM, Aklillu E. Optimal single sampling time-point for monitoring of praziquantel exposure in children. Sci Rep 2021;11:17955. [PMID: 34504222 DOI: 10.1038/s41598-021-97409-x] [Reference Citation Analysis]
11 Ollivier C, Thomson A, Manolis E, Blake K, Karlsson KE, Knibbe CAJ, Pons G, Hemmings R. Commentary on the EMA Reflection Paper on the use of extrapolation in the development of medicines for paediatrics. Br J Clin Pharmacol 2019;85:659-68. [PMID: 30707770 DOI: 10.1111/bcp.13883] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
12 Aurich B, Jacqz-Aigrain E. Drug Safety in Translational Paediatric Research: Practical Points to Consider for Paediatric Safety Profiling and Protocol Development: A Scoping Review. Pharmaceutics 2021;13:695. [PMID: 34064872 DOI: 10.3390/pharmaceutics13050695] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 O'Hara K, Martin JH, Schneider JJ. Barriers and Challenges in Performing Pharmacokinetic Studies to Inform Dosing in the Neonatal Population. Pharmacy (Basel) 2020;8:E16. [PMID: 32033361 DOI: 10.3390/pharmacy8010016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Grounds MD, Terrill JR, Al-Mshhdani BA, Duong MN, Radley-Crabb HG, Arthur PG. Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress. Dis Model Mech 2020;13:dmm043638. [PMID: 32224496 DOI: 10.1242/dmm.043638] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
15 Sathe AG, Brundage RC, Ivaturi V, Cloyd JC, Chamberlain JM, Elm JJ, Silbergleit R, Kapur J, Coles LD. A pharmacokinetic simulation study to assess the performance of a sparse blood sampling approach to quantify early drug exposure. Clin Transl Sci 2021;14:1444-51. [PMID: 33742783 DOI: 10.1111/cts.13004] [Reference Citation Analysis]
16 Zeeni C, Karam CJ, Kaddoum RN, Aouad MT. Propofol use in children: updates and controversies. Minerva Anestesiol 2020;86. [DOI: 10.23736/s0375-9393.19.14022-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Leroux S, Mechinaud-Heloury F, Jacqz-Aigrain E. Contribution of Population Pharmacokinetics of Glycopeptides and Antifungals to Dosage Adaptation in Paediatric Onco-hematological Malignancies: A Review. Front Pharmacol 2021;12:635345. [PMID: 33867986 DOI: 10.3389/fphar.2021.635345] [Reference Citation Analysis]
18 Eke AC, Olagunju A, Best BM, Mirochnick M, Momper JD, Abrams E, Penazzato M, Cressey TR, Colbers A. Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV. Clin Pharmacokinet 2020;59:1185-94. [PMID: 32757103 DOI: 10.1007/s40262-020-00915-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Fresnais M, Roth A, Foerster KI, Jäger D, Pfister SM, Haefeli WE, Burhenne J, Longuespée R. Rapid and Sensitive Quantification of Osimertinib in Human Plasma Using a Fully Validated MALDI-IM-MS/MS Assay. Cancers (Basel) 2020;12:E1897. [PMID: 32674434 DOI: 10.3390/cancers12071897] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Barry E, Walsh JA, Weinrich SL, Beaupre D, Blasi E, Arenson DR, Jacobs IA. Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations. Paediatr Drugs 2021;23:381-94. [PMID: 34173206 DOI: 10.1007/s40272-021-00455-1] [Reference Citation Analysis]